Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-18 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-17 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-09 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-07 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |